跳至主要内容
临床试验/CTRI/2023/12/060532
CTRI/2023/12/060532尚未招募3 期

Efficacy of oral Curcuma longa as an add on therapy with standard anti tuberculosis treatment compared to standard anti tuberculosis treatment alone in newly diagnosed sputum positive drug sensitive pulmonary tuberculosis patients – A randomized double blinded placebo controlled trial - NI

Jawarhalal Institute of Post Graduate Medical Education and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Newly diagnosed smear positive drug sensitive pulmonary tuberculosis patients who have at least one sputum smear samples positive for tubercle bacilli (at least 1+) by auramine rhodamine staining- Patients willing to come for regular followup

排除标准

  • -Patient with HIV
  • -Patients diagnosed with Chronic Kidney disease and Chronic liver disease requiring dose modifications.
  • -Pregnant and lactating women.
  • -Newly diagnosed tuberculosis patients with respiratory failure

研究者

发起方
Jawarhalal Institute of Post Graduate Medical Education and Research

相似试验